March 18, 2019 — With mere days left before his departure as FDA Commissioner, Dr. Scott Gottlieb is trying to focus attention on one of the lesser-known of his major initiatives – improving the design of clinical trials in drug development. In a statement released along with the publication of a new guidance, Gottlieb highlighted […]
Read more
By Michael Parenti, Senior Engagement Strategist, Saatchi & Saatchi Wellness Feb. 1, 2019 — On Oct. 25, 2018, the Centers for Medicare and Medicaid Services (CMS) issued an advance notice of proposed rulemaking (ANPRM) to test whether phasing down the Medicare payment amount for selected Part B drugs to more closely align with international prices […]
Read moreJuly 2, 2013 – In a recent blog post on Drugwonks.com, entitled “The Ecosystem of Medical Innovation,” Peter Pitts forwarded some “solid directional guidance” from Bob Hugin, CEO of Celgene and the new Chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA). Hugin states that medical innovation is “the crown jewel of America and […]
Read more